Microfluidic Cell Retention Device for Perfusion of Mammalian Suspension Culture

Abstract Continuous production of biologics, a growing trend in the biopharmaceutical industry, requires a reliable and efficient cell retention device that also maintains cell viability. Current filtration methods, such as tangential flow filtration using hollow-fiber membranes, suffer from membran...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Taehong Kwon, Holly Prentice, Jonas De Oliveira, Nyasha Madziva, Majid Ebrahimi Warkiani, Jean-François P. Hamel, Jongyoon Han
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/f3245607a2aa4041aa73c8e026a442cd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f3245607a2aa4041aa73c8e026a442cd
record_format dspace
spelling oai:doaj.org-article:f3245607a2aa4041aa73c8e026a442cd2021-12-02T11:53:00ZMicrofluidic Cell Retention Device for Perfusion of Mammalian Suspension Culture10.1038/s41598-017-06949-82045-2322https://doaj.org/article/f3245607a2aa4041aa73c8e026a442cd2017-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-06949-8https://doaj.org/toc/2045-2322Abstract Continuous production of biologics, a growing trend in the biopharmaceutical industry, requires a reliable and efficient cell retention device that also maintains cell viability. Current filtration methods, such as tangential flow filtration using hollow-fiber membranes, suffer from membrane fouling, leading to significant reliability and productivity issues such as low cell viability, product retention, and an increased contamination risk associated with filter replacement. We introduce a novel cell retention device based on inertial sorting for perfusion culture of suspended mammalian cells. The device was characterized in terms of cell retention capacity, biocompatibility, scalability, and long-term reliability. This technology was demonstrated using a high concentration (>20 million cells/mL) perfusion culture of an IgG1-producing Chinese hamster ovary (CHO) cell line for 18–25 days. The device demonstrated reliable and clog-free cell retention, high IgG1 recovery (>99%) and cell viability (>97%). Lab-scale perfusion cultures (350 mL) were used to demonstrate the technology, which can be scaled-out with parallel devices to enable larger scale operation. The new cell retention device is thus ideal for rapid perfusion process development in a biomanufacturing workflow.Taehong KwonHolly PrenticeJonas De OliveiraNyasha MadzivaMajid Ebrahimi WarkianiJean-François P. HamelJongyoon HanNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-11 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Taehong Kwon
Holly Prentice
Jonas De Oliveira
Nyasha Madziva
Majid Ebrahimi Warkiani
Jean-François P. Hamel
Jongyoon Han
Microfluidic Cell Retention Device for Perfusion of Mammalian Suspension Culture
description Abstract Continuous production of biologics, a growing trend in the biopharmaceutical industry, requires a reliable and efficient cell retention device that also maintains cell viability. Current filtration methods, such as tangential flow filtration using hollow-fiber membranes, suffer from membrane fouling, leading to significant reliability and productivity issues such as low cell viability, product retention, and an increased contamination risk associated with filter replacement. We introduce a novel cell retention device based on inertial sorting for perfusion culture of suspended mammalian cells. The device was characterized in terms of cell retention capacity, biocompatibility, scalability, and long-term reliability. This technology was demonstrated using a high concentration (>20 million cells/mL) perfusion culture of an IgG1-producing Chinese hamster ovary (CHO) cell line for 18–25 days. The device demonstrated reliable and clog-free cell retention, high IgG1 recovery (>99%) and cell viability (>97%). Lab-scale perfusion cultures (350 mL) were used to demonstrate the technology, which can be scaled-out with parallel devices to enable larger scale operation. The new cell retention device is thus ideal for rapid perfusion process development in a biomanufacturing workflow.
format article
author Taehong Kwon
Holly Prentice
Jonas De Oliveira
Nyasha Madziva
Majid Ebrahimi Warkiani
Jean-François P. Hamel
Jongyoon Han
author_facet Taehong Kwon
Holly Prentice
Jonas De Oliveira
Nyasha Madziva
Majid Ebrahimi Warkiani
Jean-François P. Hamel
Jongyoon Han
author_sort Taehong Kwon
title Microfluidic Cell Retention Device for Perfusion of Mammalian Suspension Culture
title_short Microfluidic Cell Retention Device for Perfusion of Mammalian Suspension Culture
title_full Microfluidic Cell Retention Device for Perfusion of Mammalian Suspension Culture
title_fullStr Microfluidic Cell Retention Device for Perfusion of Mammalian Suspension Culture
title_full_unstemmed Microfluidic Cell Retention Device for Perfusion of Mammalian Suspension Culture
title_sort microfluidic cell retention device for perfusion of mammalian suspension culture
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/f3245607a2aa4041aa73c8e026a442cd
work_keys_str_mv AT taehongkwon microfluidiccellretentiondeviceforperfusionofmammaliansuspensionculture
AT hollyprentice microfluidiccellretentiondeviceforperfusionofmammaliansuspensionculture
AT jonasdeoliveira microfluidiccellretentiondeviceforperfusionofmammaliansuspensionculture
AT nyashamadziva microfluidiccellretentiondeviceforperfusionofmammaliansuspensionculture
AT majidebrahimiwarkiani microfluidiccellretentiondeviceforperfusionofmammaliansuspensionculture
AT jeanfrancoisphamel microfluidiccellretentiondeviceforperfusionofmammaliansuspensionculture
AT jongyoonhan microfluidiccellretentiondeviceforperfusionofmammaliansuspensionculture
_version_ 1718394961166073856